RE:RE:Rêve ou réalité...? The crazy thing about these projections is that they have already been exceeded. The revenue for 2021 will come out far and above the projections for 2022.
Q1 2021 ~$6.9million
Q2 2021 ~$5.5 million
Q3 2021 ~$3.9 million
As they had assets of over $4 million in test kits at the beginning of Q4 the annual financials could show revenues of over $20 million for 2021. If profits continued to rise in Q4, and they should have, they might very well reach their projected profit target of $1.7 million.
The first half of 2022 should be equally as exciting and will provide some significant updates on where the pandemic and testing is headed for the second half of 2022. In the meantime with a 300% increase in testing for the foreseeable future Q1 and Q2 2022 should see the company easily meeting revenues that are in line with the projections for the first half of 2023.
Profits equals exposure equals opportunity to expand.Beyond that will be challenging to predict until investors see what management hopes to do to diversify ....this will be an exciting time for sure.
Now, let's see a concurrent move in the sp!!!
mellocello wrote: In its power point presentation on page 8. Screenpro forecasts revenues of 16.2 million for 2022 (profit 4.5 million) 27 million for 2023 (profit 8 million) and 37 million for 2024 (profit 11 million) as the presentation dated last month. August we can think that the revenues of 2022 will be rather those of 2024 (300% more tests) if we apply the profits of 11 million on 420 million shares we have a profit per share of 0.0261 and for a company whose income increases by more than 50% per year we can put a multiple of 20 or 0.0261 X 20 = 0.52 the value of the share for 2022 currently 0.025 ..... good luck all https://63b84a7c-fd9e-4cf9-84fc -fb94608ff8e4.filesusr.com/ugd/490d4d_ca956cba570048279affc283930a2241.pdf